Clinical trials with psychopharmacologic drugs - a regulatory point of view

被引：0
|
作者：
Broich, K [1 ]
机构：
[1] Bundesinst Arzneimittel & Med Prod, Bonn, Germany
来源：
PHARMACOPSYCHIATRY | 2005年 / 38卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：233 / 233
页数：1
相关论文
共 50 条
  • [31] PSYCHOPHARMACOLOGIC AND CLINICAL CLASSIFICATION OF THE VARIOUS NEUROLEPTIC DRUGS - GENERAL THERAPEUTICAL INDICATIONS IN PSYCHOSIS
    LAMBERT, PA
    REVOL, L
    PRESSE MEDICALE, 1960, 68 (41): : 1509 - 1511
  • [32] CLINICAL PHARMACOKINETICS - CURRENT REQUIREMENTS AND FUTURE PERSPECTIVES FROM A REGULATORY POINT-OF-VIEW
    SHAH, RR
    XENOBIOTICA, 1993, 23 (11) : 1159 - 1193
  • [33] Clinical research activities during COVID-19: the point of view of a promoter of academic clinical trials
    Linda Valmorri
    Bernadette Vertogen
    Chiara Zingaretti
    Anna Miserocchi
    Roberta Volpi
    Alberto Clemente
    Isabella Bondi
    Irene Valli
    Britt Rudnas
    Giovanni Martinelli
    Oriana Nanni
    BMC Medical Research Methodology, 21
  • [34] Clinical research activities during COVID-19: the point of view of a promoter of academic clinical trials
    Valmorri, Linda
    Vertogen, Bernadette
    Zingaretti, Chiara
    Miserocchi, Anna
    Volpi, Roberta
    Clemente, Alberto
    Bondi, Isabella
    Valli, Irene
    Rudnas, Britt
    Martinelli, Giovanni
    Nanni, Oriana
    BMC MEDICAL RESEARCH METHODOLOGY, 2021, 21 (01)
  • [35] RADIOSENSITIZING DRUGS - A CLINICAL VIEW
    DISCHE, S
    BRITISH JOURNAL OF RADIOLOGY, 1988, 61 (729): : 868 - 868
  • [36] Annual review 2002 -: Psychopharmacologic drugs
    Mealy, NE
    Castañer, R
    Martín, L
    del Fresno, M
    Revel, L
    Bayés, M
    Stringer, M
    Sorbera, LA
    Cole, P
    Cullell-Young, M
    Leeson, PA
    Prous, J
    DRUGS OF THE FUTURE, 2002, 27 (10) : 995 - 1018
  • [37] Interactions of alternative medicine and psychopharmacologic drugs
    Habermeyer, E.
    Becker, S.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2008, 18 : S567 - S567
  • [38] Internet of Things from a regulatory point of view
    Hadzovic, Suada
    2021 20TH INTERNATIONAL SYMPOSIUM INFOTEH-JAHORINA (INFOTEH), 2020,
  • [39] PHARMACOKINETICS - REGULATORY ASPECTS - POINT OF VIEW OF FDA
    TESKE, RH
    NEWKIRK, DR
    VETERINARY AND HUMAN TOXICOLOGY, 1990, 32 (03) : 261 - 262
  • [40] LABORATORY QUALITY ASSURANCE - A REGULATORY POINT OF VIEW
    MCKULLY, KA
    HALISKY, TE
    CANADIAN INSTITUTE OF FOOD SCIENCE AND TECHNOLOGY JOURNAL-JOURNAL DE L INSTITUT CANADIEN DE SCIENCE ET TECHNOLOGIE ALIMENTAIRES, 1983, 16 (03): : R12 - R12
12345